Research - Strasbourg, Grand Est, France
Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases.
ShareThis
WordPress.org
Google Font API
Google Tag Manager
Google Analytics
Bootstrap Framework